DEI Biopharma
@deibiopharma.com
Advancing Healthcare Through Innovation Dei BioPharma is building Africa’s largest state-of-the-art pharmaceutical and biotech facility, pioneering the future of medicine with cutting-edge RNA technology and high-quality vaccines. Learn More High-Quality, Affordable Medicines for All Our facility adheres to stringent US FDA, EU EMA, and WHO GMP standards, ensuring life-saving medicines and vaccines reach those who need them most. Learn More From Uganda to the World We are set to launch across Africa, Europe, and the US, revolutionizing pharmaceutical accessibility with innovative solutions and global partnerships. Learn More Self-reliant African Healthcare Dei BioPharma is at the forefront of revolutionizing African healthcare by pioneering biotech and pharmaceutical advancements. With a cutting-edge facility and a commitment to innovation, we aim to make high-quality medicines and vaccines accessible across the continent and beyond. Africa’s first biotech and pharmaceutical research firm. Meeting global GMP standards: US FDA, EMA, WHO Certified Pharma $2.5 billion valued state-of-the-art Biological, Pharmaceutical and Healthcare project Over 100 patents filed with the USPTO One billion doses of mRNA vaccines annually African Healthcare Transformation with global leaders. Pioneering Healthcare Innovation for a Better Future Dei Biopharma specializes in developing and manufacturing innovative medicines and vaccines. It was commissioned on July 6, 2021, by President Yoweri Museveni and Kenya President William Ruto (then Vice President). Iconic drugs and vaccines manufacturing facility in Mattuga, Wakiso District, Uganda. Africa’s largest biopharma icon, leading pharmaceutical innovation on the continent. Accessible, affordable, and innovative healthcare for Africa’s self-reliance in medicines and healthcare. Explore More Our Innovative Healthcare Solutions Biologics Therapeutics As a leader in biologics, we produce safe and cost-effective alternatives to traditional therapies. Medicines We address critical therapeutic areas, including infectious diseases, cancer, and chronic conditions, and we produce generics and nutraceuticals. Vaccines for Global Health Crises We innovate vaccines to reduce the threat of diseases. Advanced Research We leverage cutting-edge research and world-class manufacturing to develop innovative pharmaceutical solutions. No Community Left Behind Thinking Global, Caring Local While we are breaking ground as the first African biopharma company to enter Europe, the USA, and other developed markets, we remain committed to creating an impact in Africa and Uganda by creating jobs, pushing for sustainability, boosting healthcare access with affordable medicines, and growing talent through education and training programs. Discover how we're making a difference What Experts Think About Us This plant meets the world standards, at least the first bits that I have seen…. Local production is one of the ways of solving the problem of fake drugs so that the population consumes the right medicine. Prof. John B. Kaneene Dei Biopharma Ltd is different from other foreign biotechnology companies such as Moderna that are being hosted by African countries. John Patrick Amama Mbabazi Our Leadership Team Our leadership team combines decades of pharmaceuticals, biotechnology, and global healthcare expertise. Together, they lead DEI BioPharma in its mission to redefine healthcare for the better View All Dr. Matthias Magoola Managing Director Kellen Kamurungi Executive Director Get in Touch Dei Biopharma is always open to collaborations, partnerships, and inquiries. Whether you’re a healthcare provider, researcher, or global partner, we’d love to hear from you. Our Address Block 82, plot 988 – 990 & 3325 – 3326 Kigogwa, Kiryamuli, Matugga – Bombo Road P. O. Box 35854, Kampala, Uganda. Contact Info +256 414 660519 Our latest News & Blogs edit post Museveni praises Dr. Magoola’s leadership of the knowledge economy as he launches 2026 NRM Manifesto KAMPALA – President Yoweri Museveni has indicated that the Ugandan economy will rip big from the knowledge economy, including biotechnology… Continue Read edit post TOP STORY: Dei BioPharma chief Magoola gets US FDA waiver for the clinical trial period for his new cancer therapies KAMPALA, Uganda — The U.S. Food and Drug Administration (FDA) has agreed to waive clinical efficacy testing requirements for two… Continue Read edit post Dei Biopharma founder Dr. Magoola honored with Lifetime Achievement Award in Canada BRAMPTON, Ontario — Dr. Matthias Magoola, a Ugandan scientist and founder of Dei Biopharma Ltd., has been honored with the… Continue Read View All
DEI Biopharma's Company Logos
DEI Biopharma's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#CF2E2E
Persian Red
207, 46, 46
0, 64, 50
0, 78, 78, 19
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#32373C
Outer Space
50, 55, 60
210, 9, 22
17, 8, 0, 76
About DEI Biopharma
Dei BioPharma Ltd. is a groundbreaking pharmaceutical brand that is revolutionizing healthcare in Africa. Our state-of-the-art Drugs and Vaccines Manufacturing Plant in Matugga, Wakiso District, is set to produce high-quality yet affordable medicines, including treatments for cancer and malaria. Committed to making a difference in the lives of millions of families across the continent, we are the sole African company manufacturing Covid-19 therapeutic medications and aiming to produce 1 billion doses of mRNA vaccines to WHO standards.
Led by our visionary Managing Director, Dr. Mathias Magoola, we have a wide array of formulations for drugs, vaccines, anti-cancer medications, and more. Upholding values of innovation, quality, reliability, integrity, and customer focus, we are dedicated to empowering Africa through cutting-edge research, manufacturing, and technology. Supported by a strong financial base and a commitment to creating 40,000 direct jobs, Dei BioPharma is poised to lead Africa towards self-sustainability in healthcare. Join us in our mission to transform healthcare and empower communities across the continent.
